Opportunity

Simpler Grants.gov #PAR-25-338

NIH Grant for Translational Technologies in Disease Diagnosis and Treatment (R01, No Clinical Trials)

Buyer

National Institutes of Health

Posted

December 31, 2024

Respond By

January 07, 2028

Identifier

PAR-25-338

NAICS

541715, 541714, 541330

This opportunity from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), seeks to fund partnerships translating scientific and engineering advances into new technologies for disease research and care. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - OEMs and Vendors: - No specific OEMs or vendors are named in this opportunity - Products/Services Requested: - Development of new methods, tools, or technologies for disease understanding, risk assessment, detection, prevention, diagnosis, treatment, and management - Focus on translational technologies applicable to pre-clinical, clinical, and non-clinical settings - No specific part numbers or quantities; proposals should address relevant research and care delivery needs - Unique or Notable Requirements: - Clinical trials are not allowed under this opportunity - Open to a broad range of applicants, including businesses, government entities, educational institutions, and nonprofits - No cost sharing or matching requirement - Technologies must align with the missions of participating NIH institutes - Funding: - Maximum funding amount is $499,000 - Period of Performance: - Applications accepted until January 7, 2028 (specific project duration not detailed) - Place of Performance: - National Institutes of Health (federal office)

Description

The National Cancer Institute (NCI) seeks to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic and applied research related to disease understanding, risk assessment, detection, prevention, diagnosis, treatment, and management. The goal is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to research and care delivery in pre-clinical, clinical, and non-clinical settings for conditions and diseases within the missions of participating institutes. Eligible applicants include a wide range of organizations such as businesses, government entities, educational institutions, nonprofits, and other specified groups. The funding instrument is a grant with a funding amount of $499,000 and no cost sharing or matching requirement.

View original listing